Can a car be a copyrightable character? In Carroll Shelby Licensing v. Halicki, the Ninth Circuit said no — ruling that “Eleanor,” the iconic Mustang from ‘Gone in 60 Seconds,’ lacks the distinctiveness and consistency required for copyright protection.
Recent PTAB Developments for Regeneron’s Aflibercept Formulation Patent
Earlier this month, a Patent Trial and Appeal Board (“PTAB”) panel denied institution of two petitions that were filed separately by Samsung Bioepis (IPR2025-00176) and Formycon (IPR2025-00233) for inter partes review (“IPR”) of Regeneron’s U.S. Patent No. 11,084,865 (the “’865 patent”).
Regeneron Files Another Complaint Against Amgen in Aflibercept BPCIA Litigation
On June 17, 2025, Regeneron Pharmaceuticals, Inc. (“Regeneron”) filed another complaint against Amgen Inc. (“Amgen”) under the BPCIA, alleging that Amgen’s aflibercept biosimilar, PAVBLU®, infringes U.S. Patent No. 12,331,099 (“the ’099 patent”). The ’099 patent issued on the same day,
Driving towards the legalisation of fully autonomous vehicles in the UK
As many will know, the Autonomous Vehicle Act 2024 (the “AV Act”) paved the way to legalising the use of autonomous vehicles on UK roads. However, before any autonomous vehicles can be used on the UK roads (other than under
Major setback for Tiktok’s trademark rights in India
By Gaurav Bhalla of Ahlawat & Associates
The Bombay High Court recently affirmed the order of the Registrar of Trade Marks whereby TikTok’s application for declaration of its mark as well-known in India was disallowed. Interestingly, this decision (by the
Model Law: The New York State Fashion Workers Act
On June 19, 2025, the New York State Fashion Workers Act (the “Act”) goes into effect, triggering numerous changes to the current employment structure for models in New York. The Act,[1] which Governor Hochul signed into law in December
Plan Our Adventure
Operating a company or a department within a company is quite an adventure. With adventures, a lot can go right and a lot can go wrong and a lot can go absolute nowhere and waste a whole lot of time.
Discretionary Denials in Action: iRhythm Technologies Inc. v. Welch Allyn Inc.
The U.S. Patent and Trademark Office (“USPTO”) Acting Director’s recent decision to deny institution of inter partes review (“IPR”) in iRhythm Technologies Inc. v. Welch Allyn Inc. offers valuable lessons for both patent owners and patent challengers navigating the PTAB’s
Beyond Training Sets: EUIPO Study Insights on GenAI and Copyright
Introduction
This is the first part of four-part series on the EUIPO study on GenAI and copyright. In this first part, we set out the scope and purpose of the EUIPO study and offer a general refresher on the state
TTAB Draws the Line on “See Prior Arguments”
In a precedential opinion issued June 6, 2025, the United States Patent and Trademark Office’s (“USPTO”) Trademark Trial and Appeal Board (“TTAB”) affirmed the refusal to register PRINCETON EQUITY GROUP as a trademark for “strategic financial advisory services; providing equity